RxDoctor Payments Data

Patricia Sylla, MD

Colon & Rectal Surgery · Boston, MANPI 1639212020

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $98,116 of the $139,421 with a category attached, or 70.4%. 24 manufacturers reported payments, led by Johnson & Johnson at 25.0% of the total. Among colon & rectal surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$139,421in general payments, 2019–2025

Across 143 payments — averaging $974.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$35K
  • Medtronic$25K
  • Stryker$18K
  • Medical Device Business Services, Inc.$14K
  • Olympus America Inc.$13K
  • Heron Therapeutics, Inc.$10K
  • plus $25K from 18 others
$302,722in research payments, 2019–2025

Across 17 payments — averaging $17,807 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ethicon Endo-surgery Inc.$94K
  • Covidien LP$75K
  • Conmed Corporation$50K
  • Olympus Corporation Of The Americas$40K
  • Stryker$30K
  • Medical Device Business Services, Inc.$14K
  • plus $250 from 1 others

What the payments were for

  • Consulting fees$98,11670%
  • Speaking & faculty fees$17,78013%
  • Travel & lodging$20,46715%
  • Food & beverage$3,0592%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$139,421 in reported general payments places this provider in the 95th percentile of 49 colon & rectal surgery providers in Massachusetts.

See all colon & rectal surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$30,019
Medicare patients
51
Services billed
123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other colon & rectal surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →